Published in Biochemistry on January 13, 2014
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol (1973) 47.81
On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun (1967) 18.32
The risk associated with aprotinin in cardiac surgery. N Engl J Med (2006) 10.98
Epidemiology of trauma deaths: a reassessment. J Trauma (1995) 6.60
The behavior and significance of slow-binding enzyme inhibitors. Adv Enzymol Relat Areas Mol Biol (1988) 5.84
Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature (1983) 5.27
Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol (2005) 4.03
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2007) 3.28
Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res (1981) 3.00
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet (1999) 2.77
Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry (1991) 2.66
Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J Biol Chem (1991) 2.61
Plasminogen activator inhibitors. Blood (1987) 2.38
The cell biology of the plasminogen system. FASEB J (1995) 2.30
Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci U S A (1989) 2.26
Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors. Can J Anaesth (2011) 2.24
Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest (2008) 2.16
Structure and function of the plasminogen/plasmin system. Thromb Haemost (2005) 2.02
The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action. Nat Struct Biol (1998) 1.85
Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem (1992) 1.82
Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator. FEBS Lett (1983) 1.56
Convulsive seizures following subdural application of fibrin sealant containing tranexamic acid in a rat model. Neurosurgery (2000) 1.52
Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator. J Clin Invest (1984) 1.52
Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol (1998) 1.48
Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood (1984) 1.44
The Cheng-Prusoff relationship: something lost in the translation. Trends Pharmacol Sci (1993) 1.42
Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery: yes. J Thromb Haemost (2006) 1.41
Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proc Natl Acad Sci U S A (1994) 1.38
Plasmin as a proinflammatory cell activator. J Leukoc Biol (2012) 1.38
Thrombin specificity. Requirement for apolar amino acids adjacent to the thrombin cleavage site of polypeptide substrate. Eur J Biochem (1985) 1.37
Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. J Exp Med (2003) 1.35
Structure and biology of tissue factor pathway inhibitor. Thromb Haemost (2001) 1.29
Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization. Biochem J (1995) 1.27
Seizures after open heart surgery: comparison of ε-aminocaproic acid and tranexamic acid. J Cardiothorac Vasc Anesth (2011) 1.25
Mechanism of the urokinase-catalyzed activation of human plasminogen. J Biol Chem (1976) 1.23
The X-ray crystal structure of full-length human plasminogen. Cell Rep (2012) 1.22
Quantitative determination of the binding of epsilon-aminocaproic acid to native plasminogen. J Biol Chem (1978) 1.22
Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem (1997) 1.21
Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry (1996) 1.21
Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase. Thromb Res (2000) 1.17
In vivo significance of kinetic constants of protein proteinase inhibitors. Biochem Med (1984) 1.16
Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin. J Biol Chem (1985) 1.15
Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells. Clin Exp Metastasis (1998) 1.15
Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid. Biochim Biophys Acta (1974) 1.14
Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin. J Biol Chem (1991) 1.12
Comparison of some properties of native (Glu) and modified (Lys) human plasminogen. J Biol Chem (1978) 1.12
Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin, and plasmin. Proc Soc Exp Biol Med (1971) 1.12
Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation. J Biol Chem (1993) 1.11
Plasminogen has a broad extrahepatic distribution. Thromb Haemost (2002) 1.11
On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid. J Biol Chem (1986) 1.11
Fast-acting plasmin inhibitor in human plasma. Blood (1978) 1.10
Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2. Arch Biochem Biophys (1996) 1.07
The effect of epsilon-amino caproic acid on the gross conformation of plasminogen and plasmin. Arch Biochem Biophys (1975) 1.07
Laminin interacts with plasminogen and its tissue-type activator. FEBS Lett (1984) 1.04
Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system. J Biol Chem (1990) 1.04
Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling. Hematology Am Soc Hematol Educ Program (2001) 1.04
Evaluation of aprotinin and tranexamic acid in different in vitro and in vivo models of fibrinolysis, coagulation and thrombus formation. J Thromb Haemost (2007) 1.04
Crystal structure of Kunitz domain 1 (KD1) of tissue factor pathway inhibitor-2 in complex with trypsin. Implications for KD1 specificity of inhibition. J Biol Chem (2005) 1.02
Structure-function analysis of the reactive site in the first Kunitz-type domain of human tissue factor pathway inhibitor-2. J Biol Chem (2004) 1.00
Regulation of plasminogen receptor expression on human monocytes and monocytoid cell lines. J Cell Biol (1990) 0.99
So many plasminogen receptors: why? J Biomed Biotechnol (2012) 0.98
Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest (2012) 0.97
The cell-binding domains of plasminogen and their function in plasma. J Biol Chem (1988) 0.95
Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide. Biochem J (1998) 0.95
Effects of cardiac surgery on hemostasis. Transfus Med Rev (2006) 0.93
cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2. J Biochem (1994) 0.91
Concentrations of binding protein and labeled analyte that are appropriate for measuring at any analyte concentration range in radioimmunoassays. Methods Enzymol (1981) 0.90
Identification of the domains of tissue-type plasminogen activator involved in the augmented binding to fibrin after limited digestion with plasmin. J Biol Chem (1989) 0.90
Tissue factor-like activity of the human monocytic tumor cell line U937. Thromb Res (1982) 0.87
Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands epsilon-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid. Biochemistry (1996) 0.87
Critical role for conversion of glu-plasminogen to Lys-plasminogen for optimal stimulation of plasminogen activation on cell surfaces. Trends Cardiovasc Med (2003) 0.87
Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety. J Cardiothorac Vasc Anesth (2013) 0.86
Plaminogen is synthesized by primary cultures of rat hepatocytes. Science (1980) 0.86
Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro. J Biol Chem (1992) 0.85
Engineering kunitz domain 1 (KD1) of human tissue factor pathway inhibitor-2 to selectively inhibit fibrinolysis: properties of KD1-L17R variant. J Biol Chem (2010) 0.84
Antifibrinolytics in cardiac surgery. Ann Card Anaesth (2013) 0.84
Effectors of the activation of human [Glu1]plasminogen by human tissue plasminogen activator. Biochemistry (1988) 0.83
Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions. Ann Thorac Surg (2005) 0.83
Production and release of plasminogen by isolated perfused rat liver. Proc Natl Acad Sci U S A (1980) 0.81
Refolding, purification, and activation of miniplasminogen and microplasminogen isolated from E. coli inclusion bodies. Protein Expr Purif (2006) 0.80
Aprotinin; friend or foe? A review of recent medical literature. Eur J Anaesthesiol (2006) 0.79
Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin. J Biol Chem (1990) 0.77
[Monitoring blood coagulation in larger liver operations]. Infusionsther Transfusionsmed (1993) 0.77
Convulsions induced by aminocaproic acid infusion. DICP (1989) 0.77
Aprotinin in cardiac surgery: a different point of view. Heart Surg Forum (2008) 0.77
Comparative effects of aprotinin and human recombinant R24K KD1 on temporal renal function in Long-Evans rats. J Pharmacol Exp Ther (2009) 0.76
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum (2007) 2.90
Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res (2008) 2.81
The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res (2008) 2.53
Target identification using drug affinity responsive target stability (DARTS). Proc Natl Acad Sci U S A (2009) 2.40
Human body fluid proteome analysis. Proteomics (2006) 2.39
Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics (2005) 2.34
Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. J Biol Chem (2003) 2.30
Heme is involved in microRNA processing. Nat Struct Mol Biol (2006) 2.27
Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat Immunol (2005) 2.24
Cardiolipin defines the interactome of the major ADP/ATP carrier protein of the mitochondrial inner membrane. J Cell Biol (2008) 2.18
Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants. Proc Natl Acad Sci U S A (2006) 2.13
Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation. Sci Signal (2010) 2.05
The cell-shape protein MreC interacts with extracytoplasmic proteins including cell wall assembly complexes in Caulobacter crescentus. Proc Natl Acad Sci U S A (2005) 1.96
Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry. J Proteome Res (2006) 1.96
Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity. Cell (2007) 1.89
An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS. Lab Chip (2006) 1.88
EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infection. Proc Natl Acad Sci U S A (2012) 1.81
Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. Cancer Res (2009) 1.79
Systems biology approach in Chlamydomonas reveals connections between copper nutrition and multiple metabolic steps. Plant Cell (2011) 1.74
Top-down ESI-ECD-FT-ICR mass spectrometry localizes noncovalent protein-ligand binding sites. J Am Chem Soc (2006) 1.68
ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. EMBO J (2006) 1.59
Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin Appl (2009) 1.51
Genetic and proteomic evidence for roles of Drosophila SUMO in cell cycle control, Ras signaling, and early pattern formation. PLoS One (2009) 1.48
Sizing large proteins and protein complexes by electrospray ionization mass spectrometry and ion mobility. J Am Soc Mass Spectrom (2007) 1.46
New reagents for increasing ESI multiple charging of proteins and protein complexes. J Am Soc Mass Spectrom (2009) 1.46
Retracted A new strategy for the synthesis of glycoproteins. Science (2004) 1.44
High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+, and Zn2+ sites in factor VIIa. J Biol Chem (2006) 1.42
Systems and trans-system level analysis identifies conserved iron deficiency responses in the plant lineage. Plant Cell (2012) 1.38
Network organization of the huntingtin proteomic interactome in mammalian brain. Neuron (2012) 1.38
Increasing charge while preserving noncovalent protein complexes for ESI-MS. J Am Soc Mass Spectrom (2008) 1.34
The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome. Mol Biol Cell (2008) 1.30
Non-mitochondrial complex I proteins in a hydrogenosomal oxidoreductase complex. Nature (2004) 1.26
Connecting actin monomers by iso-peptide bond is a toxicity mechanism of the Vibrio cholerae MARTX toxin. Proc Natl Acad Sci U S A (2008) 1.25
Lysine-specific molecular tweezers are broad-spectrum inhibitors of assembly and toxicity of amyloid proteins. J Am Chem Soc (2011) 1.25
The vault exterior shell is a dynamic structure that allows incorporation of vault-associated proteins into its interior. Biochemistry (2006) 1.22
Protein-Sequence Polymorphisms and Post-translational Modifications in Proteins from Human Saliva using Top-Down Fourier-transform Ion Cyclotron Resonance Mass Spectrometry. Int J Mass Spectrom (2007) 1.22
Digital microfluidics with in-line sample purification for proteomics analyses with MALDI-MS. Anal Chem (2005) 1.22
Human saliva proteome analysis and disease biomarker discovery. Expert Rev Proteomics (2007) 1.18
Human saliva proteome analysis. Ann N Y Acad Sci (2007) 1.16
Site-specific incorporation of a redox-active amino acid into proteins. J Am Chem Soc (2003) 1.16
Structure of the dimerization domain of DiGeorge critical region 8. Protein Sci (2010) 1.16
Top-Down Mass Spectrometry of Supercharged Native Protein-Ligand Complexes. Int J Mass Spectrom (2011) 1.15
Anthrax lethal toxin induced lysosomal membrane permeabilization and cytosolic cathepsin release is Nlrp1b/Nalp1b-dependent. PLoS One (2009) 1.14
Enhanced FASP (eFASP) to increase proteome coverage and sample recovery for quantitative proteomic experiments. J Proteome Res (2014) 1.14
Structural characterization of unsaturated phosphatidylcholines using traveling wave ion mobility spectrometry. Anal Chem (2009) 1.12
Identification and solution structure of a highly conserved C-terminal domain within ORF1p required for retrotransposition of long interspersed nuclear element-1. J Biol Chem (2007) 1.12
Differentially expressed protein markers in human submandibular and sublingual secretions. Int J Oncol (2004) 1.11
Oxidative stress and asthma: proteome analysis of chitinase-like proteins and FIZZ1 in lung tissue and bronchoalveolar lavage fluid. J Proteome Res (2009) 1.10
Amino acid position-specific contributions to amyloid beta-protein oligomerization. J Biol Chem (2009) 1.10
Mapping the cofilin binding site on yeast G-actin by chemical cross-linking. J Mol Biol (2008) 1.09
Oligomers of ERBB3 have two distinct interfaces that differ in their sensitivity to disruption by heregulin. J Biol Chem (2004) 1.09
Electrowetting-based microfluidics for analysis of peptides and proteins by matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem (2004) 1.07
Probing the mechanism of electron capture and electron transfer dissociation using tags with variable electron affinity. J Am Chem Soc (2009) 1.07
Use of a fluorescent phosphoprotein dye to characterize oxidative stress-induced signaling pathway components in macrophage and epithelial cultures exposed to diesel exhaust particle chemicals. Electrophoresis (2005) 1.06
Reconstitution of the mia40-erv1 oxidative folding pathway for the small tim proteins. Mol Biol Cell (2009) 1.05
Pro-oxidative DEP chemicals induce heat shock proteins and an unfolding protein response in a bronchial epithelial cell line as determined by DIGE analysis. Proteomics (2007) 1.04
Reactive-electrospray-assisted laser desorption/ionization for characterization of peptides and proteins. Anal Chem (2008) 1.04
Elucidating the site of protein-ATP binding by top-down mass spectrometry. J Am Soc Mass Spectrom (2010) 1.03
Crystal structure of Kunitz domain 1 (KD1) of tissue factor pathway inhibitor-2 in complex with trypsin. Implications for KD1 specificity of inhibition. J Biol Chem (2005) 1.02
A novel "molecular tweezer" inhibitor of α-synuclein neurotoxicity in vitro and in vivo. Neurotherapeutics (2012) 1.01
Incubated protein reduction and digestion on an electrowetting-on-dielectric digital microfluidic chip for MALDI-MS. Anal Chem (2010) 1.01
Structure-function analysis of the reactive site in the first Kunitz-type domain of human tissue factor pathway inhibitor-2. J Biol Chem (2004) 1.00
Mass spectrometry of protein-ligand complexes: enhanced gas-phase stability of ribonuclease-nucleotide complexes. J Am Soc Mass Spectrom (2008) 1.00
A heparin-mimicking polymer conjugate stabilizes basic fibroblast growth factor. Nat Chem (2013) 0.99
The Trichomonas vaginalis hydrogenosome proteome is highly reduced relative to mitochondria, yet complex compared with mitosomes. Int J Parasitol (2011) 0.98
Staphylococcus aureus uses a novel multidomain receptor to break apart human hemoglobin and steal its heme. J Biol Chem (2012) 0.97
Analysis of PTEN complex assembly and identification of heterogeneous nuclear ribonucleoprotein C as a component of the PTEN-associated complex. J Biol Chem (2009) 0.97
The proteome of copper, iron, zinc, and manganese micronutrient deficiency in Chlamydomonas reinhardtii. Mol Cell Proteomics (2012) 0.97
Mapping of drebrin binding site on F-actin. J Mol Biol (2010) 0.96
Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding. J Mol Biol (2005) 0.95
Ion mobility-mass spectrometry of phosphorylase B ions generated with supercharging reagents but in charge-reducing buffer. Phys Chem Chem Phys (2010) 0.95
Fe sparing and Fe recycling contribute to increased superoxide dismutase capacity in iron-starved Chlamydomonas reinhardtii. Plant Cell (2012) 0.95
S-layer, surface-accessible, and concanavalin A binding proteins of Methanosarcina acetivorans and Methanosarcina mazei. J Proteome Res (2009) 0.94
Electrospray-assisted laser desorption/ionization and tandem mass spectrometry of peptides and proteins. Rapid Commun Mass Spectrom (2007) 0.94
Confident assignment of intact mass tags to human salivary cystatins using top-down Fourier-transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom (2010) 0.94
Synthetic approach to homodimeric protein-polymer conjugates. Chem Commun (Camb) (2009) 0.94
Structural and functional studies of γ-carboxyglutamic acid domains of factor VIIa and activated Protein C: role of magnesium at physiological calcium. J Mol Biol (2013) 0.93
Structure-function relationships in factor IX and factor IXa. Trends Cardiovasc Med (2003) 0.93
A sequential mechanism for exosite-mediated factor IX activation by factor XIa. J Biol Chem (2012) 0.93
Retraction. Science (2009) 0.92
Nitrotyrosine-modified proteins and oxidative stress induced by diesel exhaust particles. Electrophoresis (2005) 0.92
Direct ionization of large proteins and protein complexes by desorption electrospray ionization-mass spectrometry. Anal Chem (2011) 0.92
The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor. J Biol Chem (2001) 0.91
Zinc deficiency impacts CO2 assimilation and disrupts copper homeostasis in Chlamydomonas reinhardtii. J Biol Chem (2013) 0.91
Native protein MS and ion mobility large flying proteins with ESI. Anal Chem (2007) 0.91
Synthesis of Maleimide-End Functionalized Star Polymers and Multimeric Protein-Polymer Conjugates. Macromolecules (2009) 0.90
Revealing ligand binding sites and quantifying subunit variants of noncovalent protein complexes in a single native top-down FTICR MS experiment. J Am Soc Mass Spectrom (2014) 0.90
Adjuvant effects of ambient particulate matter monitored by proteomics of bronchoalveolar lavage fluid. Proteomics (2010) 0.89
Integration of protein processing steps on a droplet microfluidics platform for MALDI-MS analysis. Anal Chem (2010) 0.89
Mass spectrometry detection and characterization of noncovalent protein complexes. Methods Mol Biol (2009) 0.89
Structural biology of factor VIIa/tissue factor initiated coagulation. Front Biosci (Landmark Ed) (2012) 0.89
Conformation and dynamics of the SH1-SH2 helix in scallop myosin. Biochemistry (2003) 0.89
What protein charging (and supercharging) reveal about the mechanism of electrospray ionization. J Am Soc Mass Spectrom (2014) 0.89